D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -43.29M -43.68M -32.26M -141.37M -41.63M
Total Depreciation and Amortization 383.00K 385.00K 390.00K 405.00K 417.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 13.86M 13.38M 4.94M 102.41M 2.92M
Change in Net Operating Assets 10.21M 4.70M -2.15M -2.19M 8.91M
Cash from Operations -18.85M -25.22M -29.08M -40.74M -29.38M
Capital Expenditure -- -- -- -- 1.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 21.16M -90.82M -8.56M 30.05M 22.64M
Cash from Investing 21.16M -90.82M -8.56M 30.05M 22.64M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 42.14M 5.83M 1.40M 7.03M 5.00M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock 0.00 0.00 138.85M -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3.81M -3.34M 5.93M -2.78M -2.57M
Cash from Financing 38.33M 2.49M 146.18M 4.24M 2.42M
Foreign Exchange rate Adjustments 977.00K -603.00K -301.00K -71.00K -192.00K
Miscellaneous Cash Flow Adjustments 1.00K -1.00K -- -- --
Net Change in Cash 41.62M -114.15M 108.24M -6.52M -4.51M
Weiss Ratings